Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-22

Clinical Trial Update: Serum Pharmacokinetic Disposition and Urinary Excretion of Albendazole [Phase 1]

View source ↗

Summary

A Phase 1 trial update evaluating the pharmacokinetic disposition and urinary excretion of albendazole. The study targets soil-transmitted helminthiasis as part…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albendazole (ALBENDAZOLE)

Snippet

Sponsor: Universidad Nacional de Salta | Conditions: Soil Transmitted Helminthiasis, Neglected Tropical Diseases | Phase 1 | Status: COMPLETED